123 related articles for article (PubMed ID: 37423567)
1. Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy.
Neves R; Tseng AS; Garmany R; Fink AL; McLeod CJ; Cooper LT; MacIntyre CJ; Homb AC; Rosenbaum AN; Bois JP; Abou Ezzeddine OF; Siontis KC; Pereira NL; Ackerman MJ; Giudicessi JR
Int J Cardiol; 2023 Oct; 389():131173. PubMed ID: 37423567
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of
Protonotarios A; Wicks E; Ashworth M; Stephenson E; Guttmann O; Savvatis K; Sekhri N; Mohiddin SA; Syrris P; Menezes L; Elliott P
Int J Cardiol; 2019 Jun; 284():99-104. PubMed ID: 30409737
[TBL] [Abstract][Full Text] [Related]
3. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis.
Tung R; Bauer B; Schelbert H; Lynch JP; Auerbach M; Gupta P; Schiepers C; Chan S; Ferris J; Barrio M; Ajijola O; Bradfield J; Shivkumar K
Heart Rhythm; 2015 Dec; 12(12):2488-98. PubMed ID: 26272522
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of myocardial washout of
Suzuki M; Izawa Y; Fujita H; Miwa K; Takahashi Y; Toh H; Toba T; Fujiwara S; Hashimura H; Kono AK; Hirata KI
Ann Nucl Med; 2022 Jun; 36(6):544-552. PubMed ID: 35303274
[TBL] [Abstract][Full Text] [Related]
5. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of fluorine-18 fluoro-2-deoxyglucose positron emission computed tomography in patients with unexplained atrioventricular block.
Danwade TA; Devidutta S; Shelke AB; Saggu DK; Yalagudri SD; Sridevi C; Reddy NK; Narasimhan C
Heart Rhythm; 2018 Feb; 15(2):234-239. PubMed ID: 29061522
[TBL] [Abstract][Full Text] [Related]
7. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
[TBL] [Abstract][Full Text] [Related]
8. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?
Chen W; Jeudy J
Curr Cardiol Rep; 2019 Jun; 21(8):76. PubMed ID: 31243587
[TBL] [Abstract][Full Text] [Related]
10. Testicular fluorine-18 fludeoxyglucose uptake on positron emission tomography CT in patients with lymphoma: clinical significance and management impact.
Sidhu P; Lin P; Son H; Rosenfeld D; Lin M
Br J Radiol; 2014 Dec; 87(1044):20140472. PubMed ID: 25333503
[TBL] [Abstract][Full Text] [Related]
11. Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.
Amigues I; Tugcu A; Russo C; Giles JT; Morgenstein R; Zartoshti A; Schulze C; Flores R; Bokhari S; Bathon JM
Arthritis Rheumatol; 2019 Apr; 71(4):496-506. PubMed ID: 30407745
[TBL] [Abstract][Full Text] [Related]
12. Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse.
Miller MA; Adams DH; Pandis D; Robson PM; Pawale A; Pyzik R; Liao SL; El-Eshmawi A; Boateng P; Garg J; Waterford S; Weiner MM; Dukkipati SR; Reddy VY; Fayad ZA; Trivieri MG
JAMA Cardiol; 2020 Sep; 5(9):1000-1005. PubMed ID: 32936270
[TBL] [Abstract][Full Text] [Related]
13. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.
Peretto G; Busnardo E; Ferro P; Palmisano A; Vignale D; Esposito A; De Luca G; Campochiaro C; Sartorelli S; De Gaspari M; Rizzo S; Dagna L; Basso C; Gianolli L; Della Bella P; Sala S
JACC Cardiovasc Imaging; 2022 Oct; 15(10):1771-1780. PubMed ID: 36202457
[TBL] [Abstract][Full Text] [Related]
14. Incremental Prognostic Value of Global Longitudinal Strain and 18F-Fludeoxyglucose Positron Emission Tomography in Patients With Systemic Sarcoidosis.
Sperry BW; Ibrahim A; Negishi K; Negishi T; Patel P; Popović ZB; Culver D; Brunken R; Marwick TH; Tamarappoo B
Am J Cardiol; 2017 May; 119(10):1663-1669. PubMed ID: 28343598
[TBL] [Abstract][Full Text] [Related]
15. Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium.
Ozawa K; Funabashi N; Daimon M; Takaoka H; Takano H; Uehara M; Kobayashi Y
Int J Cardiol; 2013 Nov; 169(3):196-200. PubMed ID: 24075573
[TBL] [Abstract][Full Text] [Related]
16. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
[TBL] [Abstract][Full Text] [Related]
17. Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients.
Marmursztejn J; Guillevin L; Trebossen R; Cohen P; Guilpain P; Pagnoux C; Mouthon L; Legmann P; Vignaux O; Duboc D
Rheumatology (Oxford); 2013 Apr; 52(4):642-50. PubMed ID: 22772324
[TBL] [Abstract][Full Text] [Related]
18. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
19. Pre-Treatment Myocardial
Subramanian M; Swapna N; Ali AZ; Saggu DK; Yalagudri S; Kishore J; Swamy LTN; Narasimhan C
JACC Cardiovasc Imaging; 2021 Oct; 14(10):2008-2016. PubMed ID: 33454258
[TBL] [Abstract][Full Text] [Related]
20. Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.
Ito K; Okazaki O; Morooka M; Kubota K; Minamimoto R; Hiroe M
Intern Med; 2014; 53(18):2041-9. PubMed ID: 25224185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
